This histopathological improvement, consistent with serum biomarker normalization (Figure 2), collectively demonstrates SPP’s capacity to alleviate HUA-induced nephropathy by restoring the renal microstructure and mitigating inflammation. Here, HM13 is linked to kidney disorder.